$0.770
+0.0148 (+1.96%)
At Close: Jul 31, 2026
Artelo Biosciences, Inc. (ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid system, announced today that positive non-clinical data with the C
Artelo Biosciences to Present at the Annual Investival Showcase in London
02:00pm, Thursday, 14'th Nov 2019
LA JOLLA, Calif., Nov. 14, 2019 -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid.
Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART27.13
12:30pm, Tuesday, 29'th Oct 2019
LA JOLLA, Calif., Oct. 29, 2019 -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid.
Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
01:00pm, Tuesday, 22'nd Oct 2019
LA JOLLA, Calif., Oct. 22, 2019 -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the endocannabinoid.
Knowledge of the health benefits of cannabinoids appears to be spreading to the general population and many people are asking how cannabinoids work to benefit health. The short answer is that cannabin
Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature Medicine
12:00pm, Wednesday, 18'th Sep 2019
LA JOLLA, Calif., Sept. 18, 2019 -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate the.
Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th
01:00pm, Wednesday, 11'th Sep 2019
LA JOLLA, CA / ACCESSWIRE / September 11, 2019 / Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocan
What Percentage Of Artelo Biosciences, Inc. (NASDAQ:ARTL) Shares Do Insiders Own?
05:34pm, Wednesday, 04'th Sep 2019
A look at the shareholders of Artelo Biosciences, Inc. (NASDAQ:ARTL) can tell us which group is most powerful...
CBD Oil Benefits, Tips, & Information | Ganjapreneur
05:42pm, Friday, 30'th Aug 2019
CBD oil benefits are endless, so the claims say. In this post we dive deeper in to how effective CBD is, how you use it, and more.
Accelerating the Dell EMC Partnership with the ‘New’ Cloudera | Direct2DellEMC
01:00pm, Tuesday, 13'th Aug 2019
The platform design paradigm from the early days of Hadoop has been to co-locate compute and storage on the same server, which requires expanding both in
Product Profiles: Emerald Health Bioceuticals | WholeFoods Magazine
04:00pm, Thursday, 18'th Jul 2019
Powerful Support for the Endocannabinoid System—BEYOND CBD Advanced Support for the Endocannabinoid System Emerald Health Bioceuticals is a global leader in phytocannabinoid science, tapping into na
Help Your Customers Focus on Their Data | Direct2DellEMC
01:00pm, Friday, 12'th Apr 2019
Dell EMC ECS 3.3 software upgrade helps customers unlock value – and helps you protect your revenue and boost your business Sometimes – in business as
Every day we hear of a growing number of enterprises joining the ranks of modern, data-driven organizations. These organizations leverage technology and
Apprenticeship will tech the boxes for Scot
04:32pm, Thursday, 04'th Oct 2018
The 22-year-old is working towards a qualification as part of a technical apprenticeship.
One Technology Provider for All Your Media Pro Needs | Direct2DellEMC
06:01pm, Monday, 09'th Apr 2018
We are thrilled to be able to showcase our end-to-end infrastructure and technology solutions at the 2018 NAB Show in Las Vegas, spanning Dell EMC storage, servers and networking, VMware virtualizatio
Sign In
Buy ARTL